Study Summary
This trial will test whether a "Kidney Action Team" can provide better care for hospitalized patients with Acute Kidney Injury.
Eligible Conditions
- Acute Kidney Injury
Treatment Effectiveness
Effectiveness Progress
Study Objectives
1 Primary · 1 Secondary · Reporting Duration: 24 hours after randomization
Day 14
Composite outcome showing the percentage of participants with any one of the following: progression of AKI, inpatient dialysis, or inpatient death
24 hours after randomization
Percentage of recommendations implemented by the primary care team
Trial Safety
Safety Progress
Trial Design
2 Treatment Groups
Usual Care
1 of 2
Kidney Action Team Recommendations
1 of 2
Active Control
Experimental Treatment
4000 Total Participants · 2 Treatment Groups
Primary Treatment: Kidney Action Team Recommendations · No Placebo Group · N/A
Kidney Action Team Recommendations
Other
Experimental Group · 1 Intervention: Kidney Action Team Recommendations · Intervention Types: OtherUsual CareNoIntervention Group · 1 Intervention: Usual Care · Intervention Types:
Trial Logistics
Trial Timeline
Screening: ~3 weeks
Treatment: Varies
Reporting: 24 hours after randomization
Who is running the clinical trial?
Yale UniversityLead Sponsor
1,678 Previous Clinical Trials
21,083,805 Total Patients Enrolled
9 Trials studying Acute Kidney Injury
21,290 Patients Enrolled for Acute Kidney Injury
Johns Hopkins UniversityOTHER
2,073 Previous Clinical Trials
31,013,225 Total Patients Enrolled
5 Trials studying Acute Kidney Injury
5,813 Patients Enrolled for Acute Kidney Injury
Francis P WilsonPrincipal InvestigatorYale Univerisity
Eligibility Criteria
Age 18+ · All Participants · 2 Total Inclusion Criteria
Mark “Yes” if the following statements are true for you:References
- Wilson, F Perry, Michael Shashaty, Jeffrey Testani, Iram Aqeel, Yuliya Borovskiy, Susan S Ellenberg, Harold I Feldman, et al.. 2015. “Automated, Electronic Alerts for Acute Kidney Injury: A Single-blind, Parallel-group, Randomised Controlled Trial”. The Lancet. Elsevier BV. doi:10.1016/s0140-6736(15)60266-5.
- 2021. "Personalized Recommendations for Acute Kidney Injury (AKI) Care". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT04040296.
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top
Conditions
Cancer Related
Treatments